Point72 Asset Management
APTO

Point72 Asset Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Point72 Asset Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39
Closed -$77K – 1245
2020
Q4 		$77K Sell
39
-4,554
-99% -$10.7M ﹤0.01% 877
2020
Q3 		$12.4M Buy
+4,593
New +$11.5M 0.06% 367
2020
Q1 		– Sell
-1,714
Closed -$4.37M – 1165
2019
Q4 		$4.37M Sell
1,714
-3,175
-65% -$4.14M 0.02% 521
2019
Q3 		$4.59M Hold
4,889
– – 0.03% 473
2019
Q2 		$5.74M Buy
+4,889
New +$4.5M 0.03% 482

Other funds holding APTO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management's APTO Position: Q1 2021 in Review

Point72 Asset Management sold out of Aptose Biosciences, Inc. (APTO) in Q1 2021, closing a stake of 39 shares — an estimated $77K sold.

Point72 Asset Management first reported a position in APTO in Q2 2019 and held it in 5 quarters. The position peaked at $12.4M in Q3 2020. 70 funds tracked by Wall St. Rank hold APTO as of Q1 2021.

  • Point72 Asset Management reported no remaining Aptose Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Point72 Asset Management sold 39 Aptose Biosciences, Inc. shares in Q1 2021, an estimated $77K.
  • Point72 Asset Management first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 5 quarters.
  • Point72 Asset Management's Aptose Biosciences, Inc. position peaked at $12.4M in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2021.

Based on Point72 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.